Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	30.56	89.85	68.82
Graham Fair Price	13.72	14.27	12.55
PEG	44.46	1.86	-1.29
Price/Book	2.85	2.37	2.31
Price/Cash Flow	-51.23	136.30	-279.46
Prices/Earnings	-18.97	50.01	61.71
Price/Sales	132.55	28.00	12.04
Price/FCF	-51.23	136.30	-279.46
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	92.43	0.34	0.17
Operating Margin	90.64	0.19	0.10
ROA	24.24	< 0.005	< 0.005
ROE	< 0.005	0.01	26.93
ROIC	0.02	< 0.005	-43.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-55.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.14	-0.15	5.25
EPS QOQ	-0.48	0.27	-43.91
FCF QOQ	-1.45	3.13	116.13
Revenue QOQ	0.39	-0.55	42.97
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	9.00	28.64	218.18
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.31	0.31	-0.85
Quick Ratio	1.95	1.33	-31.78
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	27.36	27.62	0.94
Cash	6.00	5.25	-12.57
Capex	-0.50	-0.11	77.16
Free Cash Flow	-0.23	0.48	112.86
Revenue	5.24	2.34	-55.36
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.17	1.65	-24.31
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.32	8.78	38.98
Naive Interpretation	Member

06 - Financial Health · Weak

Rating